scispace - formally typeset
Open AccessJournal ArticleDOI

Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues

TLDR
As tumor-suppressor microRNAs,miR-449a/b, miR-34b and mi-34c cooperate and play important roles in p53 pathway and may contribute to the carcinogenesis and progression of serous ovarian carcinomas.
Abstract
Objective The aim of this study was to investigate whether miR-449a, miR-449b and miR-192 family microRNAs play the same roles in p53 pathway as miR-34 family in ovarian cancer. Methods Wild-type p53 ovarian carcinoma cell line A2780 cells were treated with genotoxic agent adriamycin. The reactivation of p53 was detected by Western blot. The expression of miR-449a/b, miR- 34a, miR-34b,miR-34c, miR-192 and miR-194 were detected by real-time quantitative PCR. Mutant p53 ovarian cancer cell line SKOV3. ipl cells were transfected with pre-microRNAs and the cell-cycle changes were detected. The expression level of miR-449a/b, miR-34a, miR-34b, miR-34c, miR-192 and miR-194 in serous ovarian carcinomas of varying grade and stage were compared with real-time PCR. Results The expressions of miR-449a/b, miR-34b and miR-34c were 19-fold to 21-fold elevated after p53 activation by genotoxic agent. Ectopic expression of miR-449b, as well as miR-34c, resulted in cell-cycle arrest in SKOV3. ipl cells: The expression of miR-449a/b was parallel with that of miR-34b, miR-34C, and Were significantly lower in late stage and high-grade serous carcinomas than in the normal fallopian tube, early stage and low-grade serous carcinomas. The expression of miR-192, miR-194 and miR-34a did not show evident features in serous ovarian carcinomas and were much lower than miR-449a/b, miR-34b and miR-34c in normal fallopian tube. Conclusions As tumor-suppressor microRNAs, miR-449a/b, miR-34b and miR- 34c cooperate and play important roles in p53 pathway. Their inactivation may contribute to the carcinogenesis and progression of serous ovarian carcinomas. Key words: MicroRNA ;  P53 pathway;  Ovarian neoplasms

read more

Citations
More filters
Journal ArticleDOI

Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer

TL;DR: This review will discuss both the currently used serum tumor markers for screening, diagnosis, monitoring of ovarian cancer, and the novel biomarkers that are now under investigation and validation.
Journal ArticleDOI

microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer

TL;DR: It is indicated that miR-124 can suppress gastric cancer cell growth by directly targeting the EZH2 gene and sensitize the treatment effect of 5-FU, and may be a new and useful approach of Gastric cancer therapy.
Journal ArticleDOI

MicroRNA-449a inhibits proliferation and induces apoptosis by directly repressing E2F3 in gastric cancer.

TL;DR: This study indicates that the miR-449a/E2F3 axis plays an important role in proliferation and apoptosis in gastric cancer, and represents a novel target for Gastric cancer therapy.
Journal ArticleDOI

MicroRNA-34 family in breast cancer: from research to therapeutic potential.

TL;DR: A better understanding of the molecular mechanisms of miR-34s will open new opportunities for the development of novel therapeutic strategies and define a new approach in identifying potential biomarkers for early diagnosis of breast cancer.
Journal ArticleDOI

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets

TL;DR: In HCC cell lines, stable overexpression of miR-449a was sufficient to inhibit cell motility in vitro, and pulmonary metastasis in vivo, and implicate the potential application in cancer therapy.
Related Papers (5)